Company intelligence / Profile preview

Taxolog, Inc.

Fairfield, New Jersey, United Stateszoominfo.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Taxolog, Inc. was a private biotech/pharma company based in New Jersey focused on developing and commercializing novel taxane-based chemotherapeutic agents for cancer treatment. Its lead programs targeted tubulin and aimed at various neoplastic indications. As of early 2025, all known clinical-stage assets have been discontinued or are pending without recent progress or approvals.

Therapeutic areas: Oncology
Modalities: Small molecules (taxane derivatives and tubulin inhibitors)
Industry: Biotech

Drug pipeline

2 assets

milataxel

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Taxolog, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taxolog, Inc..

Explore the full profile